
EP 258: The mutations hiding in healthy tissues with Inigo Martincorena of the Wellcome Sanger Institute
Show notes
This week on The Genetics Podcast, Patrick is joined by Dr. Inigo Martincorena, Group Leader at the Wellcome Sanger Institute. They discuss the discovery of widespread cancer-driver mutations in normal tissue, the role of somatic mutations in autoimmune disease, new sequencing technologies transforming the field, and the therapeutic potential of targeting these mutations.
Show Notes
0:00 Intro to The Genetics Podcast
00:59 Welcome to Inigo
01:46 How Inigo's eyelid skin study revealed widespread cancer-driver mutations
07:14 Findings from a follow-up study on esophageal tissue
10:02 How NanoSeq technology scaled somatic mutation research across tissues
12:34 The thyroid study linking somatic mutations to autoimmune disease
17:07 How escaped B cell clones evolve into polyclonal autoimmune disease
20:21 Immune gene mutations occurring in healthy aging lymphocytes
21:21 Why driver mutation clones in normal tissue rarely become cancer
24:16 Two therapeutic paradigms for targeting somatic mutations in disease
28:13 Examples of somatic rescue mutations in the colon, liver, and blood
29:20 Why clonal selection only occurs in dividing cell types
31:20 The field's remaining blind spots in mobile immune cells and rare samples
33:46 How new single-cell sequencing will link genotype to phenotype
36:03 What Inigo has learned from collaborating across Sanger's expertise
38:09 Closing remarks
Find out more